PATHOGENICITY OF HIV ISOLATES--ROLE IN FETAL TRANSMISSON
PATHOGENICITY OF HIV ISOLATES--ROLE IN FETAL TRANSMISSON
批准号:
2067313
负责人:
Fred T Valentine
金额:
$29.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-09-30 至 1995-07-31
关键词:
AIDS HIV envelope protein gp120 HIV infections cell adhesion cell mediated lymphocytolysis test chromium communicable disease transmission congenital infection embryo /fetus enzyme linked immunosorbent assay female genetic strain helper T lymphocyte human immunodeficiency virus human pregnant subject human subject in situ hybridization infant human (0-1 year) lymphocyte proliferation microorganism culture mixed lymphocyte reaction test neutralizing antibody pediatric AIDS radionuclides radiotracer recombinant proteins suppressor T lymphocyte virulence virus cytopathogenic effect virus replication
中文摘要
点击翻译按钮获取中文摘要
英文摘要
These investigations seek to understand the role of variants of HIV present
in infected, pregnant women and the immune responses to them in governing
the transmission of HIV from mother to fetus. We postulate that
transmission may occur when a critical immune response against a variant
isolate does not occur or is lost. We will isolate biological clones of
HIV from infected mothers and infants, and examine their growth rate and
syncytia-forming capacity using, in part, a new assay that quantitates the
ability of infected cells to kill noninfected CD4 positive cells by a
syncytia type of interaction that does not require that a productive
infection be established in the target cell.
In addition we will study the role of CD8 cells from infected individuals
to limit the outgrowth of different biological clones of HIV from a given
patient, as an example of cellular immunity to autologous HIV, and as a
potential method for selecting out biological variants. We will compare
the binding to CD4 of gp120 from isolates of different syncytia-forming
capacities, using both cell binding and an enzyme-linked assay we have
developed. In order to learn more about CD4 immune responses to HIV
antigens, we will study the proliferative responses of lymphocytes from
infected mothers and infants to a panel of HIV recombinant proteins and
synthetic peptides representing selected regions of gp120.
The characteristics of the biological clones of HIV isolated from mothers
and infants and the immune responses to them will be analyzed as to their
association with the transmission of HIV from mother to fetus.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Immunogenic and antigenic properties of an HIV-1 gp120-derived multiple chain peptide.
HIV-1 gp120 衍生的多链肽的免疫原性和抗原特性。
DOI:
--
发表时间:
1994
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Kelker,HC, Schlesinger,D, Valentine,FT]
通讯作者:
Valentine,FT
Center for AIDS Research
-
批准号:8053594
-
项目类别:
-
资助金额:$91.69万
-
财政年份:2010
-
负责人:Fred T Valentine
-
依托单位:
Administrative
-
批准号:8134715
-
项目类别:
-
资助金额:$22.76万
-
财政年份:2010
-
负责人:Fred T Valentine
-
依托单位:
Immunopathogenesis of acute and early HIV infection
-
批准号:7901307
-
项目类别:
-
资助金额:$43.7万
-
财政年份:2009
-
负责人:Fred T Valentine
-
依托单位:
CD4 RESPONSES TO ANTIRETROVIRAL THERAPY (ART) ALONE OR ART WITH VACCINATION
-
批准号:7718428
-
项目类别:
-
资助金额:$95.62万
-
财政年份:2008
-
负责人:Fred T Valentine
-
依托单位:
CD4 RESPONSES TO ANTIRETROVIRAL THERAPY (ART) ALONE OR ART WITH VACCINATION
-
批准号:7605744
-
项目类别:
-
资助金额:$41.27万
-
财政年份:2007
-
负责人:Fred T Valentine
-
依托单位:
CD4 RESPONSES TO ANTIRETROVIRAL THERAPY (ART) ALONE OR ART WITH VACCINATION
-
批准号:7378339
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2006
-
负责人:Fred T Valentine
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:6936123
-
项目类别:
-
资助金额:$30.7万
-
财政年份:2005
-
负责人:Fred T Valentine
-
依托单位:
ACTG A5116: PROTEASE INHIBITOR SPARING REGIMENS V NUCLEOSIDE-SPARING REGIMENS
-
批准号:7207071
-
项目类别:
-
资助金额:$0.26万
-
财政年份:2005
-
负责人:Fred T Valentine
-
依托单位:
ACTG A5082: METFORMIN & ROSIGLITAZONE IN HIV+ PTS W/ INSULIN & FAT ABNORMALITIES
-
批准号:7207082
-
项目类别:
-
资助金额:$0.77万
-
财政年份:2005
-
负责人:Fred T Valentine
-
依托单位:
ACTG A5150: VIROLOGIC & IMMUNOLOGIC CHANGES IN WOMEN WITH HIV DURING POSTPARTUM
-
批准号:7207139
-
项目类别:
-
资助金额:$0.26万
-
财政年份:2005
-
负责人:Fred T Valentine
-
依托单位:
OAR Supplement
-
批准号:7124499
-
项目类别:
-
资助金额:$35.91万
-
财政年份:2005
-
负责人:Fred T Valentine
-
依托单位:
ACTG 5084: METABOLIC COMPLICATIONS IN HIV-1-INFECTED PREGNANT WOMEN ON ART
-
批准号:7207088
-
项目类别:
-
资助金额:$0.13万
-
财政年份:2005
-
负责人:Fred T Valentine
-
依托单位:
ACTG A5150: VIROLOGIC & IMMUNOLOGIC CHANGES IN WOMEN WI
-
批准号:6974389
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2004
-
负责人:Fred T Valentine
-
依托单位:
AUGMENTATION OF IMMUNE RESPONSE THROUGH VACCINATION IN INDIVIDUALS ON HAART
-
批准号:6974328
-
项目类别:
-
资助金额:$0.63万
-
财政年份:2004
-
负责人:Fred T Valentine
-
依托单位:
ACTG A5092s: Pharmacokinetic Effects of RBV on ZDV or d4T Triphosphate Formation
-
批准号:6974338
-
项目类别:
-
资助金额:$1.27万
-
财政年份:2004
-
负责人:Fred T Valentine
-
依托单位:
Immune responses to acute HIV infection
-
批准号:6808337
-
项目类别:
-
资助金额:$14.32万
-
财政年份:2004
-
负责人:Fred T Valentine
-
依托单位:
Immunological control of HIV in vivo
-
批准号:6808334
-
项目类别:
-
资助金额:$14.26万
-
财政年份:2004
-
负责人:Fred T Valentine
-
依托单位:
ACTG A5143: Lopinavir (LPV)/Ritonavir (RTV) vs GW433908/RTV vs LPV/RTV/GW433908
-
批准号:6974335
-
项目类别:
-
资助金额:$1.27万
-
财政年份:2004
-
负责人:Fred T Valentine
-
依托单位:
ACTG A5173:CLEARANCE OF HIV-1 IN CD4+ CELLS OF SUBJECTS ON T-20 PLUS ORAL AR
-
批准号:6974384
-
项目类别:
-
资助金额:$0.24万
-
财政年份:2004
-
负责人:Fred T Valentine
-
依托单位:
ACTG 362: Azithromycin Prophylaxis for Primary Prevention of MAC in AIDS
-
批准号:6974253
-
项目类别:
-
资助金额:$0.79万
-
财政年份:2004
-
负责人:Fred T Valentine
-
依托单位: